Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin
NCT02620696
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
ECL-cell Hyperplasia
Parietal-cell Hyperplasia
Rebound Hyperacidity
Dyspepsia
Interventions
DRUG:
netazepide
Sponsor
Trio Medicines Ltd.